Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2026-09-17 17:03:38 ET · period of report 2026-09-15 · accession 0001193125-26-394488 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 17:03 | 2026-09-15 | DLB | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | A - Grant | $0.00 | +48.1K | 119.0K | +68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-15 | A | A | 48,076 | $0.00 | 119,024 | D | — | — | (F1) Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. (F2) Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. (F3) Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |